HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirofumi Kawakubo Selected Research

C-Reactive Protein

11/2021Lymphocyte-to-C-Reactive Protein Ratio as a Novel Marker for Predicting Oncological Outcomes in Patients with Esophageal Cancer.
5/2021Factors predicting major complications, mortality, and recovery in percutaneous endoscopic gastrostomy.
1/2020Clinical significance of preoperative serum concentrations of interleukin-6 as a prognostic marker in patients with esophageal cancer.
4/2016Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study.
12/2015Correlation Between Intense Postoperative Inflammatory Response and Survival of Esophageal Cancer Patients Who Underwent Transthoracic Esophagectomy.
1/2015Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirofumi Kawakubo Research Topics

Disease

94Esophageal Neoplasms (Esophageal Cancer)
04/2024 - 05/2009
53Neoplasms (Cancer)
04/2024 - 12/2003
42Esophageal Squamous Cell Carcinoma
04/2024 - 04/2014
24Stomach Neoplasms (Stomach Cancer)
05/2024 - 05/2009
13Pneumonia (Pneumonitis)
08/2023 - 05/2015
12Anastomotic Leak
10/2023 - 03/2014
11Neoplasm Metastasis (Metastasis)
09/2023 - 09/2013
10Lymphatic Metastasis
11/2023 - 01/2014
8Carcinoma (Carcinomatosis)
10/2020 - 08/2008
7Adenocarcinoma
05/2024 - 12/2012
7Inflammation (Inflammations)
01/2024 - 09/2013
5Residual Neoplasm
06/2023 - 07/2019
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2023 - 06/2008
4Breast Neoplasms (Breast Cancer)
03/2007 - 12/2003
3Sepsis (Septicemia)
08/2023 - 10/2020
3Sarcopenia
01/2023 - 09/2021
3Deglutition Disorders (Dysphagia)
01/2023 - 05/2021
3Surgical Wound Infection
01/2023 - 01/2019
3Acute Lung Injury
09/2017 - 05/2015
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
10/2023 - 04/2012
2Weight Loss (Weight Reduction)
04/2023 - 12/2015
2Hypersensitivity (Allergy)
01/2023 - 07/2018
2Peptic Esophagitis (Reflux Esophagitis)
01/2023 - 11/2020
2Surgical Wound
01/2023 - 01/2019
2Infections
11/2021 - 10/2020
2Aspiration Pneumonia
05/2021 - 04/2019
2Peritonitis
12/2020 - 09/2013
2Pancreatic Neoplasms (Pancreatic Cancer)
04/2019 - 12/2012
2Thyroid Neoplasms (Thyroid Cancer)
11/2018 - 01/2018
2COVID-19 related adult multisystem inflammatory disease
03/2007 - 10/2006
2Prostatic Neoplasms (Prostate Cancer)
10/2006 - 03/2004
1Pathologic Complete Response
01/2024
1Carcinosarcoma
10/2023
1Melanoma (Melanoma, Malignant)
10/2023
1Hemorrhage
10/2023
1Acute Kidney Injury (Acute Renal Failure)
10/2023
1Body Weight (Weight, Body)
09/2023

Drug/Important Bio-Agent (IBA)

9Cisplatin (Platino)FDA LinkGeneric
07/2023 - 01/2014
8CytokinesIBA
01/2024 - 09/2013
6AlbuminsIBA
09/2023 - 01/2015
6Fibrinogen (Factor I)FDA Link
10/2022 - 01/2015
6C-Reactive ProteinIBA
11/2021 - 01/2015
5Indicators and Reagents (Reagents)IBA
02/2024 - 01/2015
5Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2015
4Interleukin-8 (Interleukin 8)IBA
01/2024 - 08/2015
4Therapeutic UsesIBA
08/2023 - 01/2023
4Coloring Agents (Dyes)IBA
01/2018 - 09/2014
4AldehydesIBA
05/2017 - 06/2008
4NF-kappa B (NF-kB)IBA
03/2007 - 12/2003
3Interleukin-6 (Interleukin 6)IBA
01/2024 - 08/2015
3N-acetyltalosaminuronic acid (NAT)IBA
11/2023 - 01/2023
3Fluorouracil (Carac)FDA LinkGeneric
07/2023 - 01/2019
3Docetaxel (Taxotere)FDA Link
07/2023 - 07/2018
3Circulating Tumor DNAIBA
06/2023 - 01/2023
3olanexidineIBA
01/2023 - 01/2019
3Proteins (Proteins, Gene)FDA Link
12/2019 - 10/2004
3SolutionsIBA
07/2019 - 09/2014
3TinIBA
01/2018 - 09/2014
3Colloids (Colloid)IBA
01/2018 - 09/2014
3Anti-Mullerian HormoneIBA
03/2007 - 12/2003
2MicroRNAs (MicroRNA)IBA
04/2024 - 10/2022
2Protons (Proton)IBA
10/2023 - 11/2020
2A-factor (Streptomyces)IBA
05/2021 - 07/2006
2InterleukinsIBA
12/2020 - 09/2013
2Povidone-Iodine (Betadine)FDA LinkGeneric
11/2020 - 01/2019
2IodineIBA
11/2018 - 06/2012
2Technetium-99IBA
12/2016 - 09/2014
2ParaffinIBA
08/2015 - 01/2013
2Transforming Growth Factor beta (TGF-beta)IBA
03/2007 - 10/2006
2AndrogensIBA
10/2006 - 03/2004
2Cyclin D1IBA
07/2006 - 10/2004
1Immune Checkpoint InhibitorsIBA
10/2023
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2023
1Carcinoembryonic AntigenIBA
10/2023
1Tumor Biomarkers (Tumor Markers)IBA
10/2023
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2023
1Hemoglobins (Hemoglobin)IBA
09/2023
1GhrelinIBA
09/2023

Therapy/Procedure

75Esophagectomy
02/2024 - 01/2012
35Neoadjuvant Therapy
02/2024 - 01/2014
23Gastrectomy
05/2024 - 04/2012
21Lymph Node Excision (Lymph Node Dissection)
03/2023 - 01/2012
13Chemoradiotherapy
02/2024 - 12/2012
11Drug Therapy (Chemotherapy)
10/2023 - 05/2014
9Radiotherapy
10/2023 - 12/2012
9Therapeutics
07/2023 - 07/2018
6Operative Surgical Procedures
02/2023 - 01/2013
5Enteral Nutrition (Feeding, Tube)
01/2023 - 05/2015
3Combined Modality Therapy
10/2023 - 01/2019
3Epidural Analgesia
12/2022 - 12/2022
3Combination Drug Therapy (Combination Chemotherapy)
04/2020 - 12/2012
3Minimally Invasive Surgical Procedures
01/2020 - 07/2017
3Laparotomy
08/2015 - 01/2007
2Aftercare (After-Treatment)
02/2024 - 02/2022
2Length of Stay
04/2022 - 12/2015
2Ligation
12/2020 - 09/2013
2Punctures
12/2020 - 09/2013
2Transplantation
01/2018 - 06/2014
2Thoracotomy
10/2016 - 08/2015
1Proton Therapy
10/2023